Melodiol Global Health (AU:ME1) has released an update.
William Lay, a director at Melodiol Global Health Limited, has experienced a change in interests due to the expiry of options. Specifically, Lay’s indirect interest through Noble House Consulting Ltd has decreased following the expiry of 16,667 ME1OPT41 Options and 16,667 ME1OPT42 Options, both on September 6, 2024. The remaining securities held by the director include 70,834 Fully Paid Ordinary Shares and various other options and performance rights.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
